{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 16,
        "end": 27
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 33,
        "end": 44
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 77,
        "end": 81
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 16,
        "end": 44
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "26984388_6",
  "text": "In conclusion , cobimetinib plus vemurafenib is a valuable option for use in BRAF ( V600 ) mutation-positive unresectable or metastatic melanoma ."
}
